DIPG

Clinical trials for DIPG explained in plain language.

Never miss a new study

Get alerted when new DIPG trials appear

Sign up with your email to follow new studies for DIPG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New radioactive drug targets childhood cancers that Won't quit

Disease control Ongoing

This early-stage trial tests a radioactive drug called CLR 131 in 30 children and young adults with solid tumors, lymphoma, or brain tumors that have come back or not responded to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. P…

Matched conditions: DIPG

Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC

DIPG

Get alerted when new DIPG trials appear

New radioactive drug targets childhood cancers that Won't quit